These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21103226)

  • 1. Increases in Nonspecific Immunoglobulin E and Eosinophils after H. pylori Eradication.
    Matsukawa Y; Gon Y; Hemmi A; Takeuchi J; Sawada S; Hayashi I
    Case Rep Gastroenterol; 2010 Feb; 4(1):41-45. PubMed ID: 21103226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
    Bhasin DK; Sharma BC; Ray P; Pathak CM; Singh K
    Helicobacter; 2000 Jun; 5(2):84-7. PubMed ID: 10849056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short-term eradication therapy for Helicobacter pylori acute gastritis.
    Nomura H; Miyake K; Kashiwagi S; Sugiyama T; Asaka M
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1377-81. PubMed ID: 11197046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
    J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
    Kokkola A; Sipponen P; Rautelin H; Härkönen M; Kosunen TU; Haapiainen R; Puolakkainen P
    Aliment Pharmacol Ther; 2002 Mar; 16(3):515-20. PubMed ID: 11876705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Bozzola L; Fortunato A; Rassu M; Meli S; Soffiati G; Scagnelli M; Di Mario F; Valerio G
    J Gastroenterol Hepatol; 1999 May; 14(5):468-75. PubMed ID: 10355512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection.
    Demirci H; Uygun İlikhan S; Öztürk K; Üstündağ Y; Kurt Ö; Bilici M; Köktürk F; Uygun A
    Turk J Gastroenterol; 2015 Nov; 26(6):456-60. PubMed ID: 26510082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
    Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
    Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
    Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
    J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
    Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
    BMC Gastroenterol; 2016 Oct; 16(1):119. PubMed ID: 27716077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
    Kawai T; Takahashi S; Suzuki H; Sasaki H; Nagahara A; Asaoka D; Matsuhisa T; Masaoaka T; Nishizawa T; Suzuki M; Ito M; Kurihara N; Omata F; Mizuno S; Torii A; Kawakami K; Ohkusa T; Tokunaga K; Mine T; Sakaki N
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():29-32. PubMed ID: 25521730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
    Sheu BS; Huang JJ; Yang HB; Huang AH; Wu JJ
    Aliment Pharmacol Ther; 2003 May; 17(10):1283-90. PubMed ID: 12755841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
    Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
    Matsukawa Y; Kato K; Hatta Y; Iwamoto M; Mizuno S; Kurihara R; Arakawa Y; Kurosaka H; Hayashi I; Sawada S
    Platelets; 2007 Feb; 18(1):52-5. PubMed ID: 17365854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.